Author
Listed:
- Lars Ole Schwen
- Markus Krauss
- Christoph Niederalt
- Felix Gremse
- Fabian Kiessling
- Andrea Schenk
- Tobias Preusser
- Lars Kuepfer
Abstract
The liver is the central organ for detoxification of xenobiotics in the body. In pharmacokinetic modeling, hepatic metabolization capacity is typically quantified as hepatic clearance computed as degradation in well-stirred compartments. This is an accurate mechanistic description once a quasi-equilibrium between blood and surrounding tissue is established. However, this model structure cannot be used to simulate spatio-temporal distribution during the first instants after drug injection. In this paper, we introduce a new spatially resolved model to simulate first pass perfusion of compounds within the naive liver. The model is based on vascular structures obtained from computed tomography as well as physiologically based mass transfer descriptions obtained from pharmacokinetic modeling. The physiological architecture of hepatic tissue in our model is governed by both vascular geometry and the composition of the connecting hepatic tissue. In particular, we here consider locally distributed mass flow in liver tissue instead of considering well-stirred compartments. Experimentally, the model structure corresponds to an isolated perfused liver and provides an ideal platform to address first pass effects and questions of hepatic heterogeneity. The model was evaluated for three exemplary compounds covering key aspects of perfusion, distribution and metabolization within the liver. As pathophysiological states we considered the influence of steatosis and carbon tetrachloride-induced liver necrosis on total hepatic distribution and metabolic capacity. Notably, we found that our computational predictions are in qualitative agreement with previously published experimental data. The simulation results provide an unprecedented level of detail in compound concentration profiles during first pass perfusion, both spatio-temporally in liver tissue itself and temporally in the outflowing blood. We expect our model to be the foundation of further spatially resolved models of the liver in the future.Author Summary: The liver continuously removes xenobiotic compounds from the blood in the mammalian body. Most computational models represent the liver as composed of few well-stirred subcompartments so that a spatially resolved simulation of hepatic perfusion and compound distribution right after drug administration is currently not available. To mechanistically describe the local distribution of compounds in liver tissue during first pass perfusion, we here present a computational model which combines micro-CT based vascular structures with mass transfer descriptions used in physiologically based pharmacokinetic modeling. In the resulting spatio-temporal model, hepatic mass transfer is governed by the physiological architecture and the composition of the connecting hepatic tissue, such that hepatic heterogeneity and spatial distribution can be described mechanistically. The performance of our model is shown for exemplary compounds addressing key aspects of distribution and metabolization of drugs within a mouse liver. We furthermore investigate the impact of steatosis and carbon tetrachloride-induced liver necrosis. Notably, we find that our computational predictions are in qualitative agreement with previous experimental results in animal models. In the future, our spatially resolved model will be extended by including additional physiological information and by taking into account recirculation through the body.
Suggested Citation
Lars Ole Schwen & Markus Krauss & Christoph Niederalt & Felix Gremse & Fabian Kiessling & Andrea Schenk & Tobias Preusser & Lars Kuepfer, 2014.
"Spatio-Temporal Simulation of First Pass Drug Perfusion in the Liver,"
PLOS Computational Biology, Public Library of Science, vol. 10(3), pages 1-18, March.
Handle:
RePEc:plo:pcbi00:1003499
DOI: 10.1371/journal.pcbi.1003499
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:plo:pcbi00:1003499. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: ploscompbiol (email available below). General contact details of provider: https://journals.plos.org/ploscompbiol/ .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.